Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus

被引：6

作者：

Kim, YS

Liu, QX

Chow, LL

Chambers, HF

Täuber, MG

机构：

[1] San Francisco Gen Hosp, Infect Dis Lab, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1998年 / 42卷 / 12期

关键词：

D O I：

10.1128/AAC.42.12.3325

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The new fluoroquinolone trovafloxacin was tested against a ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus strain in the rabbit model of endocarditis. Trovafloxacin was more effective than van; comycin (CFU/g of vegetation, 2.65 +/- 1.87 versus 4.54 +/- 2.80 [mean +/- standard deviation]; P < 0.05) or ampicillin-sulbactam plus rifampin (4.9 +/- 1.1 CFU/g). The addition of ampicillin-sulbactam to trovafloxacin tended to reduce titers further.

引用

收藏

页码：3325 / 3327

页数：3

相关论文

共 31 条

[1] ANTIMICROBIAL TREATMENT OF INFECTIVE ENDOCARDITIS DUE TO VIRIDANS STREPTOCOCCI, ENTEROCOCCI, AND STAPHYLOCOCCI [J].

BISNO, AL ;

DISMUKES, WE ;

DURACK, DT ;

KAPLAN, EL ;

KARCHMER, AW ;

KAYE, D ;

RAHIMTOOLA, SH ;

SANDE, MA ;

SANFORD, JP ;

WATANAKUNAKORN, C ;

WILSON, WR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (10) :1471-1477

[2] RAPID DEVELOPMENT OF CIPROFLOXACIN RESISTANCE IN METHICILLIN-SUSCEPTIBLE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].

BLUMBERG, HM ;

RIMLAND, D ;

CARROLL, DJ ;

TERRY, P ;

WACHSMUTH, IK .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1279-1285

[3] Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin [J].

Bonilla, HF ;

Zarins, LT ;

Bradley, SF ;

Kauffman, CA .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 26 (01) :17-21

[4] METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].

BRUMFITT, W ;

HAMILTONMILLER, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (18) :1188-1196

[5] COMPARATIVE EFFICACY OF AMOXICILLIN-CLAVULANATE, CLOXACILLIN, AND VANCOMYCIN AGAINST METHICILLIN-SENSITIVE AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RATS [J].

CANTONI, L ;

WENGER, A ;

GLAUSER, MP ;

BILLE, J .

JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (05) :989-993

[6] AMPICILLIN, SULBACTAM, AND RIFAMPIN COMBINATION TREATMENT OF EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS IN RABBITS [J].

CHAMBERS, HF ;

KARTALIJA, M ;

SANDE, M .

JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (04) :897-902

[7] EFFECTS OF DOSAGE, PEAK AND TROUGH CONCENTRATIONS IN SERUM, PROTEIN-BINDING, AND BACTERICIDAL RATE ON EFFICACY OF TEICOPLANIN IN A RABBIT MODEL OF ENDOCARDITIS [J].

CHAMBERS, HF ;

KENNEDY, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (04) :510-514

[8]

CRANE LR, 1986, REV INFECT DIS, V8, P364

[9] Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus [J].

Entenza, JM ;

Vouillamoz, J ;

Glauser, MP ;

Moreillon, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1662-1667

[10] BETA-LACTAM RESISTANCE MECHANISMS OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].

FRANCIOLLI, M ;

BILLE, J ;

GLAUSER, MP ;

MOREILLON, P .

JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (03) :514-523

← 1 2 3 4 →